CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD

No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis

(2017) Joery Goossens et al.   Alzheimers Research & Therapy

Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer’s Disease: Analytical and Diagnostic Characterization

(2016) Piotr Lewczuk et al.   JOURNAL OF ALZHEIMERS DISEASE

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases

(2016) Matthias Schmitz et al.   Nature Protocols

Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years

(2012) Katharina Stoeck et al.   BRAIN

Neurochemical dementia diagnostics in Alzheimer’s disease: where are we now and where are we going?

(2011) Piotr Lewczuk et al.   Expert Review of Proteomics

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease

(2009) I. Zerr et al.   BRAIN